Hrt Financial LP Veru Inc. Transaction History

Hrt Financial LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$0.37 - $0.72 $2,950 - $5,742	-7,975 Reduced 9.33%	77,519 $54,000
Q4 2023 Feb 09, 2024	BUY	$0.67 - $1.17 $57,280 - $100,027	85,494 New	85,494 $61,000
Q2 2023 Aug 11, 2023	BUY	$0.98 - $1.49 $62,902 - $95,637	64,186 New	64,186 $76,000
Q1 2022 May 16, 2022	SELL	$4.55 - $6.41 $109,850 - $154,756	-24,143 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.89 - $9.73 $142,202 - $234,911	24,143 New	24,143 $142,000
Q3 2021 Nov 15, 2021	SELL	$6.78 - $9.89 $302,659 - $441,489	-44,640 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$7.24 - $11.2 $224,917 - $347,939	31,066 Added 228.86%	44,640 $360,000
Q1 2021 May 17, 2021	BUY	$8.05 - $20.78 $109,270 - $282,067	13,574 New	13,574 $146,000

122

56.8M

668K

531K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $46.5M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.